China’s growing biotechnology sector is facing increased scrutiny from US [...]

Pioneer Group has launched regional accelerator programmes in Cambridge and [...]

Bio-Europe is repositioning its annual conference to expand beyond its [...]

Poland-based AI drug development company Ingenix has raised €13 million [...]

Circio has raised NOK 250 million in a significantly oversubscribed [...]

TECregen, a biotechnology company focused on thymus regeneration, has completed [...]

The biopharmaceutical industry is heading into 2026 with renewed but [...]

The Biotech Growth Trust has appointed Dame Jenny Harries as [...]

Enhanced Genomics has secured an additional funding round, bringing its [...]

James Anderson is the Chair of the INTREPID Alliance and the Executive Director of Global Health at the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), a leading global organization representing pharmaceutical companies. In his role at IFPMA, James spearheads efforts to address critical global health challenges, including antimicrobial resistance, pandemic preparedness, and non-communicable diseases.